NATCO Pharma Limited(IN:NATCOPHARM)
₹808.80+0.20 (+0.02%)
IN:NATCOPHARM
NATCO Pharma Limited financials statements
₹808.80
At close:+0.20 (+0.02%)
Want to see IN:NATCOPHARM full AI Analyst Report?
NATCO Pharma Limited (NATCOPHARM) Ratios
16 Followers
NATCO Pharma Limited Ratios
IN:NATCOPHARM's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:NATCOPHARM's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.01 | 5.59 | 4.14 | 4.39 | 3.52 |
| Quick Ratio | 2.47 | 4.77 | 3.32 | 3.21 | 2.30 |
| Cash Ratio | 0.92 | 2.31 | 0.07 | 0.19 | 0.16 |
| Solvency Ratio | 0.88 | 2.03 | 1.49 | -0.25 | 0.36 |
| Operating Cash Flow Ratio | 1.05 | 1.80 | 1.25 | 1.24 | 0.07 |
| Short-Term Operating Cash Flow Coverage | 2.92 | 6.21 | 3.20 | 4.87 | 0.11 |
| Net Current Asset Value | ₹ 32.00B | ₹ 42.52B | ₹ 29.70B | ₹ 64.80B | ₹ 16.52B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.03 | 0.06 | 0.03 | 0.08 |
| Debt-to-Equity Ratio | 0.08 | 0.04 | 0.07 | 0.04 | 0.10 |
| Debt-to-Capital Ratio | 0.07 | 0.04 | 0.06 | 0.03 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.13 | 1.18 | 1.16 | 1.20 |
| Debt Service Coverage Ratio | 2.51 | 5.96 | 3.69 | 4.34 | 0.52 |
| Interest Coverage Ratio | 33.51 | 163.95 | 135.22 | 102.87 | 39.15 |
| Debt to Market Cap | 0.04 | 0.02 | 0.02 | 0.02 | 0.03 |
| Interest Debt Per Share | 41.91 | 16.62 | 22.58 | 10.44 | 24.65 |
| Net Debt to EBITDA | -0.48 | -0.88 | 0.18 | 0.05 | 1.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 83.07% | 83.59% | 81.29% | 75.84% | 69.97% |
| EBIT Margin | 37.45% | 44.36% | 39.25% | 29.90% | 6.34% |
| EBITDA Margin | 42.52% | 48.38% | 43.74% | 35.70% | 13.36% |
| Operating Profit Margin | 30.16% | 67.70% | 64.87% | 55.07% | 35.61% |
| Pretax Profit Margin | 37.70% | 51.70% | 41.82% | 31.82% | 10.39% |
| Net Profit Margin | 34.78% | 42.54% | 34.69% | 26.41% | 8.73% |
| Continuous Operations Profit Margin | 34.78% | 42.50% | 34.69% | 26.41% | 8.73% |
| Net Income Per EBT | 92.27% | 82.28% | 82.96% | 82.99% | 84.08% |
| EBT Per EBIT | 125.00% | 76.37% | 64.46% | 57.78% | 29.18% |
| Return on Assets (ROA) | 12.81% | 21.85% | 20.10% | 12.64% | 3.33% |
| Return on Equity (ROE) | 15.38% | 24.79% | 23.72% | 14.68% | 3.99% |
| Return on Capital Employed (ROCE) | 13.09% | 39.03% | 43.75% | 29.99% | 15.75% |
| Return on Invested Capital (ROIC) | 11.34% | 30.97% | 34.11% | 24.04% | 12.08% |
| Return on Tangible Assets | 13.11% | 22.54% | 20.68% | 13.08% | 3.42% |
| Earnings Yield | 8.13% | 13.08% | 7.94% | 6.95% | 1.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.58 | 3.53 | 3.15 | 3.00 | 2.84 |
| Payables Turnover | 1.69 | 2.65 | 3.18 | 2.48 | 3.61 |
| Inventory Turnover | 0.76 | 0.95 | 0.95 | 0.81 | 0.68 |
| Fixed Asset Turnover | 1.44 | 1.67 | 1.64 | 1.18 | 0.84 |
| Asset Turnover | 0.37 | 0.51 | 0.58 | 0.48 | 0.38 |
| Working Capital Turnover Ratio | 1.06 | 1.20 | 1.49 | 1.32 | 1.08 |
| Cash Conversion Cycle | 343.62 | 349.77 | 386.85 | 425.51 | 565.81 |
| Days of Sales Outstanding | 79.74 | 103.44 | 115.69 | 121.47 | 128.56 |
| Days of Inventory Outstanding | 480.24 | 384.27 | 385.96 | 451.17 | 538.29 |
| Days of Payables Outstanding | 216.36 | 137.94 | 114.81 | 147.14 | 101.04 |
| Operating Cycle | 559.98 | 487.71 | 501.66 | 572.65 | 666.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 98.74 | 94.74 | 67.50 | 46.51 | 2.55 |
| Free Cash Flow Per Share | 76.91 | 79.73 | 48.59 | 35.25 | -10.76 |
| Dividend Paid and CapEx Coverage Ratio | 3.67 | 3.33 | 2.37 | 2.77 | 0.14 |
| Capital Expenditure Coverage Ratio | 4.52 | 4.23 | 3.57 | 4.13 | 0.19 |
| Operating Cash Flow Coverage Ratio | 2.48 | 6.07 | 3.14 | 4.82 | 0.11 |
| Operating Cash Flow to Sales Ratio | 0.43 | 0.38 | 0.30 | 0.31 | 0.02 |
| Free Cash Flow Yield | 7.89% | 9.90% | 4.99% | 6.26% | -1.42% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.30 | 7.65 | 12.59 | 14.38 | 81.13 |
| Price-to-Sales (P/S) Ratio | 4.28 | 3.25 | 4.37 | 3.80 | 7.09 |
| Price-to-Book (P/B) Ratio | 1.89 | 1.90 | 2.99 | 2.11 | 3.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.67 | 10.10 | 20.04 | 15.98 | -70.30 |
| Price-to-Operating Cash Flow Ratio | 9.87 | 8.50 | 14.43 | 12.11 | 296.61 |
| Price-to-Earnings Growth (PEG) Ratio | -0.50 | 0.21 | 0.13 | 0.04 | -1.32 |
| Enterprise Value Multiple | 9.58 | 5.84 | 10.16 | 10.68 | 54.28 |
| Enterprise Value | 166.09B | 125.21B | 177.94B | 103.29B | 141.13B |
| EV to EBITDA | 9.58 | 5.84 | 10.16 | 10.68 | 54.28 |
| EV to Sales | 4.07 | 2.83 | 4.45 | 3.81 | 7.25 |
| EV to Free Cash Flow | 12.06 | 8.77 | 20.40 | 16.05 | -71.93 |
| EV to Operating Cash Flow | 9.39 | 7.38 | 14.69 | 12.16 | 303.51 |
| Tangible Book Value Per Share | 500.55 | 410.15 | 315.31 | 490.21 | 226.46 |
| Shareholders’ Equity Per Share | 514.92 | 424.71 | 326.07 | 266.96 | 233.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.18 | 0.17 | 0.17 | 0.16 |
| Revenue Per Share | 227.74 | 247.44 | 222.95 | 148.36 | 106.70 |
| Net Income Per Share | 79.21 | 105.26 | 77.34 | 39.18 | 9.32 |
| Tax Burden | 0.92 | 0.82 | 0.83 | 0.83 | 0.84 |
| Interest Burden | 1.01 | 1.17 | 1.07 | 1.06 | 1.64 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.03 | 0.03 | 0.09 |
| SG&A to Revenue | 0.00 | 0.14 | 0.00 | 0.00 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.19 | 0.90 | 0.87 | 0.99 | 0.23 |
Currency in INR
